Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Librata Endometrial Ablation Device Treatment to Reduce Menstrual Blood Loss in Sites Across the United Kingdom

NCT02971189 is registered in ClinicalTrials.gov with Birmingham Women's NHS Foundation Trust as lead sponsor.

NCT NCT02971189
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02971189 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Librata Endometrial Ablation Device Treatment to Reduce Menstrual Blood Loss in Sites Across the United Kingdom
Lead sponsor
Birmingham Women's NHS Foundation Trust
Phase
Not applicable
Overall status
Unknown status
Start date
December 31, 2016
Completion date
August 31, 2017
Enrollment
40 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

heavy menstrual bleeding